FDA Approved: INVEGA — Supplemental Application (Janssen Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Janssen's supplemental application for INVEGA (paliperidone), expanding its approved indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• INVEGA (PALIPERIDONE)

Snippet

SUPPL AP for INVEGA (PALIPERIDONE)